Cell News and Research

RSS

Educational intervention may increase awareness about kidney transplant recipients' risk of developing skin cancer

Sharing printed educational materials about the risk of squamous cell carcinoma with kidney transplant recipients appeared to be effective at increasing skin self-examination and encouraging follow-up with a dermatologist to determine risk of cancer, according to a report posted online today that will appear in the June issue of Archives of Dermatology, one of the JAMA/Archives journals.

22 Feb 2011

NYBC urges African American, Hispanic descent to donate blood for special patients

A hospitalized single mother from Queens is calling for more African Americans to become blood donors, so that she and many others may be able to live. People may call New York Blood Center at 1-800-933-BLOOD or visit www.nybloodcenter.org for more information about giving blood, and where to donate.

22 Feb 2011

Rapid advancements in joint replacement technology

Past presidents such as Gerald Ford, Ronald Reagan, and George H.W. Bush are among the millions of Americans who have undergone some form of joint replacement/repair surgery. While we see presidents come and go, advancements in joint replacement technology are up for reelection much more often.

21 Feb 2011

Advancell announces positive results from Acadra clinical study in Chronic Lymphocytic Leukemia

ADVANCELL, an emerging biopharmaceutical company, today announced positive results from a clinical study conducted with Acadra (Acadesine) in Chronic Lymphocytic Leukemia patients resistant to current therapies. The company also announced promising non-clinical results in Multiple Myeloma (MM), Mantle Cell Lymphoma (MCL) and other lymphoproliferative disorders. Synergism of Acadra in combination with current treatment in these indications has been demonstrated.

21 Feb 2011

Sheffield Bio-Science forms strategic alliance with Wockhardt to strengthen cell culture media portfolio

Sheffield Bio-Science, a Kerry Group Business, has formed a strategic global sales, marketing and development alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the Exclusive Global Sales and Distribution Partner for recombinant insulin manufactured by global Indian biotech Wockhardt. According to estimates, the potential in cell culture markets is around US$ 50 million.

21 Feb 2011

Elsevier, CJC publish 2011 issue of Canadian Journal of Cardiology

Elsevier and the Canadian Cardiovascular Society announce the publication of the January/February 2011 issue of the Canadian Journal of Cardiology, the first in their partnership. This theme issue focused on atrial fibrillation includes the long-awaited Canadian Cardiovascular Society Atrial Fibrillation Guidelines.

21 Feb 2011

Elsevier acquires Shanghai Datong Medical Information Technology

Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of Shanghai Datong Medical Information Technology Co., Ltd., a leading drug decision support provider in China.

21 Feb 2011

Canada Scholar presents research on link between cities and water-related diseases at AAAS conference

Despite clean water and improved public services, water-related diseases continues to spread in cities around the world. Vanier Canada Graduate Scholar Kate Mulligan presents her research on the connection between cities, water and health at the THINK CANADA Press Breakfast at the American Association for the Advancement of Science conference Sunday.

21 Feb 2011

International study shows reprogramming cells lead to genomic aberrations

It's a discordant note in the symphony of good news that usually accompanies stem cell research announcements. Stem cells hold enormous promise in regenerative medicine, thanks to their ability to regenerate diseased or damaged tissues.

21 Feb 2011

New research: Reovirus infected melanoma cells secrete proteins that can kill cancer

Reoviruses are successfully being used in clinical trials to treat patients with cancer. Not only does the virus cause cancer cells to die, it also forces them to release pro-inflammatory chemokines and cytokines, which in turn causes the patient's immune system to attack the disease.

21 Feb 2011

Researchers receive $2 million NIH grant to identify biomarkers in children with hemangiomas

A nearly $2 million grant from the National Institutes of Health will help investigators at Nationwide Children's Hospital search for biomarkers that may be linked to the development and outcome of hemangiomas, the most common soft tissue tumor in children.

21 Feb 2011

John Theurer chief to present videos on new limb-sparing surgical techniques at AAOS conference

James C. Wittig, M.D., chief of the division of skin and sarcoma cancer at the John Theurer Cancer Center at Hackensack University Medical Center will present eleven different educational videos on innovative approaches to orthopedic oncology at the upcoming American Academy of Orthopaedic Surgeons Conference.

20 Feb 2011

New study shows low doses of aspirin can significantly reduce risk of cancers

A new study by scientists from Oxford, Edinburgh, London and Japan shows that at low doses, aspirin can significantly reduce the risk of a range of cancers.

20 Feb 2011

Artificial blood vessel could be available ‘off the shelf’ soon

Soon artificial blood vessels could be available ‘off the shelf’. This would mean that heart bypass patients would not have to be subjected to a minor operation to graft veins from other parts of their body. This would also make life easier for surgeons as well.

20 Feb 2011

Salk receives $2 million gift to establish Endowed Chair in Vision Research

The Salk Institute for Biological Studies today announced a generous gift from Mr. Conrad Prebys, a Salk Trustee, to establish the Conrad T. Prebys Endowed Chair in Vision Research for Dr. Tom Albright. As part of their senior scientist endowed chair challenge, Joan and Irwin Jacobs will match the donor's gift with an additional $1,000,000 to establish the donor's named chair at $3,000,000.

19 Feb 2011

Life Technologies announces winners of European Ion Torrent PGM Sequencer Grants Program

Life Technologies Corporation, today announced Dr. Angel Carracedo and Dr. Mark Pallen as the winners of the European Ion Torrent Personal Genome Machine (PGM™) Sequencer Grants Program.

19 Feb 2011

American researcher awarded European Research Council Advanced Grant

One of the goals of the European Research Council, ERC, is to bring the world's leading researchers to work in Europe. American Juleen Zierath is one of those who have received funds from the ERC. She found the best environment for her research at Karolinska Institutet in Sweden.

19 Feb 2011

Protalix: New data from taliglucerase alfa, oral GCD trials to be presented at Lysosomal Disease Network Symposium

Protalix BioTherapeutics, Inc., announced today that new clinical data from the switchover trial of taliglucerase alfa in Gaucher disease patients and preclinical data on oral enzyme glucocerebrosidase (oral GCD) will be presented today at the 7th Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2011 in Las Vegas, Nevada.

19 Feb 2011

Phase I/II safety, efficacy data for Bellicum's BPX-101 presented at 2011 Genitourinary Cancers Symposium

Bellicum Pharmaceuticals, Inc. today announced the presentation of Phase I/II safety and efficacy data for BPX-101, a novel drug-activated dendritic cell vaccine for metastatic castrate resistant prostate cancer (mCRPC), in three separate posters at the 2011 Genitourinary Cancers Symposium held in Orlando, Florida on February 17 – 19, 2011.

19 Feb 2011

How Huntington's disease proteins move from cell to cell

One bad apple is all it takes to spoil the barrel. And one misfolded protein may be all that's necessary to corrupt other proteins, forming large aggregations linked to several incurable neurodegenerative diseases such as Huntington's, Parkinson's and Alzheimer's.

19 Feb 2011

Cell News and Research

Educational intervention may increase awareness about kidney transplant recipients' risk of developing skin cancer

NYBC urges African American, Hispanic descent to donate blood for special patients

Rapid advancements in joint replacement technology

Advancell announces positive results from Acadra clinical study in Chronic Lymphocytic Leukemia

Sheffield Bio-Science forms strategic alliance with Wockhardt to strengthen cell culture media portfolio

Elsevier, CJC publish 2011 issue of Canadian Journal of Cardiology

Elsevier acquires Shanghai Datong Medical Information Technology

Canada Scholar presents research on link between cities and water-related diseases at AAAS conference

International study shows reprogramming cells lead to genomic aberrations

New research: Reovirus infected melanoma cells secrete proteins that can kill cancer

Researchers receive $2 million NIH grant to identify biomarkers in children with hemangiomas

John Theurer chief to present videos on new limb-sparing surgical techniques at AAOS conference

New study shows low doses of aspirin can significantly reduce risk of cancers

Artificial blood vessel could be available ‘off the shelf’ soon

Salk receives $2 million gift to establish Endowed Chair in Vision Research

Life Technologies announces winners of European Ion Torrent PGM Sequencer Grants Program

American researcher awarded European Research Council Advanced Grant

Protalix: New data from taliglucerase alfa, oral GCD trials to be presented at Lysosomal Disease Network Symposium

Phase I/II safety, efficacy data for Bellicum's BPX-101 presented at 2011 Genitourinary Cancers Symposium

How Huntington's disease proteins move from cell to cell

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News